Page last updated: 2024-10-24

bupivacaine and Mucopolysaccharidosis I

bupivacaine has been researched along with Mucopolysaccharidosis I in 1 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Mucopolysaccharidosis I: Systemic lysosomal storage disease caused by a deficiency of alpha-L-iduronidase (IDURONIDASE) and characterized by progressive physical deterioration with urinary excretion of DERMATAN SULFATE and HEPARAN SULFATE. There are three recognized phenotypes representing a spectrum of clinical severity from severe to mild: Hurler syndrome, Hurler-Scheie syndrome and Scheie syndrome (formerly mucopolysaccharidosis V). Symptoms may include DWARFISM; hepatosplenomegaly; thick, coarse facial features with low nasal bridge; corneal clouding; cardiac complications; and noisy breathing.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yalcin, S1
Aydogan, H1
Yuce, HH1
Kucuk, A1
Boleken, ME1

Other Studies

1 other study available for bupivacaine and Mucopolysaccharidosis I

ArticleYear
Caudal anesthesia in Hurler's syndrome.
    Paediatric anaesthesia, 2011, Volume: 21, Issue:12

    Topics: Anesthesia, Caudal; Anesthetics, Inhalation; Anesthetics, Intravenous; Anesthetics, Local; Bupivacai

2011